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Edited by Sandro SonninoAbstract A new member of the UDP-N-acetylglucosamine: b-
galactose b1,3-N-acetylglucosaminyltransferase (b3Gn-T) fam-
ily having the b3-glycosyltransferase motifs was identiﬁed using
an in silico method. This novel b3Gn-T was cloned from a human
colon cancer cell line and named b3Gn-T8 based on its position
in a phylogenetic tree and enzymatic activity. b3Gn-T8 transfers
GlcNAc to the non-reducing terminus of the Galb1–4GlcNAc of
tetraantennary N-glycan in vitro. HCT15 cells transfected with
b3Gn-T8 cDNA showed an increase in reactivity to both LEA
and PHA-L4 in a ﬂow cytometric analysis. These results indi-
cated that b3Gn-T8 is involved in the biosynthesis of poly-N-
acetyllactosamine chains on tetraantennary (b1,6-branched)
N-glycan. In most of the colorectal cancer tissues examined,
the level of b3Gn-T8 transcript was signiﬁcantly higher than in
normal tissue. b3Gn-T8 could be an enzyme involved in the syn-
thesis of poly-N-acetyllactosamine on b1–6 branched N-glycans
in colon cancer.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.q The nucleotide sequence data reported in this paper will appear in
the DDBJ/GenBank Data Bank with the accession number AB175895
for human b3Gn-T8.
qq This work was performed as part of the R&D Project of the
Industrial Science and Technology Frontier Program (R&D for
Establishment and Utilization of a Technical Infrastructure for
Japanese Industry) supported by the New Energy and Industrial
Technology Development Organization (NEDO).
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Abbreviations: b3Gn-T, UDP-GlcNAc: b-galactose b1,3-N-acetylglu-
cosaminyltransferase; b3Gal-T, UDP-galactose: b-N-acetylglucos-
amine b1,3-galactosyltransferase; b3GalNAc-T, UDP-GalNAc:
b-galactose b1,3-N-acetylgalactosaminyltransferase; UDP-GlcNAc,
uridine diphosphate-N-acetylglucosamine; PBS, phosphate-buﬀered
saline; bp, base pair(s); PCR, polymerase chain reaction; FBS, fetal
bovine serum; PA, pyridylaminated
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The complex carbohydrate chains of glycoproteins (O-gly-
cans and N-glycans), glycolipids, and proteoglycans represent
secondary gene products formed through the reactions of
many glycosyltransferases. In the past few years, rapid ad-
vances in cDNA cloning achieved utilizing databases for gen-
ome and expressed sequence tag (EST) projects of human,
mouse, Caenorhabditis elegans, and Drosophila have led to
the discovery of a large number of novel glycosyltransferase
genes. We also have cloned and analyzed many human glyco-
syltransferase genes with the aid of bioinformatics technology.
Glycosyltransferases can be grouped into functional subfam-
ilies based on similarities of sequence, which reﬂect their enzy-
matic character; donor speciﬁcity, acceptor speciﬁcity, and
speciﬁc linkage between donor and acceptor. Three b3-glyco-
syltransferase (b3-GT) motifs, XIRX(S/T)W(G/L/M), (F/Y)-
XXXXDXD and (E/D)DVXXGX, which we found in a
previous study, are commonly encoded in b3-GTs that com-
bine two sugars with a b1,3-linkage [1–4]. These speciﬁc motifs
are shared by b3Gal-Ts, b3GalNAc-Ts and b3Gn-Ts. It was
suggested that these similarities may in fact reﬂect a structural
component for catalysis of the b-1,3-linkage. In the past, we
succeeded in the molecular cloning of a series of b3-GT genes.
Thirteen human b3-GTs, i.e., ﬁve b3Gal-Ts, two b3GalNAc-
Ts and six b3Gn-Ts, have been identiﬁed and reported [1–8].
Poly-N-acetyllactosamine (Polylactosamine) is a unique gly-
can comprising N-acetyllactosamine (LacNAc) repeats,
(Galb1–4GlcNAcb1–3)n, and attached toO-glycans,N-glycans
and glycolipids. Transfection experiments and in vitro enzy-
matic analysis have demonstrated that each of b3Gn-T2, -T3,
-T4, -T5, and -T7 is able to catalyze the initiation andblished by Elsevier B.V. All rights reserved.
Table 1
Substrate speciﬁcity of recombinant b3Gn-Ts for mono-, di-saccharide
and core structures of O-glycans
Acceptor substrate b3Gn-T8 b3Gn-T2 b3Gn-T7
Galb1-4GlcNAc-a-pNp 100 4592.2 100
Lactoside-a-Bz 27 1621.4 27.1
GalNAc-a-pNp ND 8.6 ND
72 H. Ishida et al. / FEBS Letters 579 (2005) 71–78elongation of polylactosamine chains, however they exhibit a
diﬀerent substrate speciﬁcity dependent on the length of the
polylactosamine chain [1,3]. Our in vitro analysis previously
demonstrated that b3Gn-T2 is most active toward polylactos-
amine substrates having 2–5 LacNAc repeats [1]. Polylactos-
amine chains are often modiﬁed to express diﬀerentiation
antigens and functional oligosaccharides. Yeh et al. [9] re-
ported that the extension of core 1 mucin-type O-glycan is di-
rected by b3Gn-T3 through addition of GlcNAc, resulting in
the synthesis of the ‘‘GlcNAcb1–3Galb1–3GalNAc-O-Ser/
Thr’’ structure. This ‘‘core 1-extended O-glycan’’ often forms
the 6-sulfo sialyl Lewis x antigen, the epitope recognized by
the monoclonal antibody MECA-79, on the terminal structure.
This epitope is known to be expressed in high endothelial ven-
ules (HEV) and function as an L-selectin ligand required for
lymphocyte homing. b3Gn-T5 exhibited the strongest activity
to transfer GlcNAc to glycolipid substrates, such as lactosyl-
ceramide (LacCer) and neolactotetraosylceramide (nLc4Cer;
paragloboside), resulting in the synthesis of Lc3Cer and neol-
actopentaosylceramide (nLc5Cer). b3Gn-T6 showed b3Gn-T
activity toward GalNAca-pNp and GalNAca1-serine/threo-
nine. b3Gn-T6 eﬀectively transferred GlcNAc to the GalNAc
residue on mucins, resulting in the synthesis of a core 3 struc-
ture. It is known that polylactosamine chains are elongated on
core 3 and/or core 4 structures [10,11]. Seko and Yamashita [8]
demonstrated that b3Gn-T7 can act on keratan sulfate
(KS)-related oligosaccharides, for example, Galb1–4ðSO3 -6Þ
GlcNAcb1–3Galb1–4ðSO3 -6ÞGlcNAc. We demonstrated that
b3Gn-T7 is also involved in the synthesis of polylactosamine
chains using HCT15 cells stably transfected with the b3Gn-
T7 gene (unpublished data). Thus, all b3Gn-Ts, b3Gn-T2,
-T3, -T4, -T5, and -T7, except for -T6, can transfer GlcNAc
to Gal with a b1,3-linkage to synthesize a polylactosamine
chain. However, each diﬀers in its preference for acceptor mol-
ecules, i.e., core 1 O-glycan, glycolipids or KS. Each enzyme
may have distinct roles in physiological processes.
Polylactosamine is often modiﬁed to carry important carbo-
hydrate structures such as Lewis-related antigens [12–15],
HNK-1 antigen [16], etc., and has many major roles in physi-
ological functions.
In cancer metastasis, polylactosamine and related structures
play important roles in cell–cell interaction, in cell-extracellu-
lar matrix (ECM) interaction [17], in immune response [18]
and in determining metastatic capacity [19]. Tri/tetra-anten-
nary (b1,6-branched) N-glycans containing polylactosamine
on a b1,6-branch act on a variety of malignant phenotypes
of tumor cells, aﬀecting cell proliferation [20] and metastatic
potential [21–26].
In this study, we cloned a novel b3Gn-T, named b3Gn-T8,
with the aid of bioinformatics. This enzyme was identiﬁed to
be a polylactosamine synthase and acted on tetraantennary
N-glycans having a b1–6 branch.Gal-a-pNp ND 16.5 0.8
Gal-b-oNp ND 24.2 2.6
Fuc-a-pNp, GalNAc-a-Bz,
GlcNAc-a-Bz, GlcNAc-b-Bz,
Glc-a-pNp, Glc-b-pNp,
Xyl-a-pNp, Xyl-b-oNp,
Man-a-Bz, ManNAc-a-Bz,
core 1-pNp, core 2-pNp,
core 3-pNp, core 6-pNp
ND NT ND
NT: not tested, ND: not detected.2. Materials and methods
2.1. Construction and puriﬁcation of human b3Gn-T8 proteins fused with
FLAG peptide
We performed a BLAST search of the EST databases and identiﬁed
a cDNA (AW444713), homologous in amino acid sequence to the open
reading frame (ORF) of b3Gn-T3 [3]. On searching the human geno-
mic DNA database, we found a single contig (AC011462) containing
the EST sequence. The putative catalytic domain of the enzyme (aminoacids 76–1194)was ampliﬁedbyPCR fromColo205 cDNAas a template
and two primers, 5 0-GCCAAGCTTACATCCGAGTCCCGGCTCA-
G-3 0 and 5 0-CGGAATTCTCAGCACTGGAGCCTTGGGT-3 0. The
ampliﬁed fragment was digested with the restriction endonucleases
HindIII and EcoRI, then inserted into pFLAG-CMV3 (Sigma, MO)
to construct pFLAG-CMV3-b3Gn-T8. The putative catalytic domain
of b3Gn-T8 was expressed as a secreted protein fused with a FLAG
peptide in 293T cells (a human embryonic renal cancer cell line). A
12-ml volume of culture medium was mixed with anti-FLAG M1 anti-
body resin (Sigma, MO). The protein–resin mixture was washed twice
with 50 mM TBS (50 nM Tris–HCl, pH 7.4, and 150 mM NaCl)
containing 1 mM CaCl2 and suspended in 100 ll of each of the assay
buﬀers.
2.2. Substrate speciﬁcity of b3Gn-T8
To determine a donor and acceptor substrate for b3Gn-T8, all com-
binations of nucleotide sugars and monosaccharides were screened by
a method described previously [4].
The basic reaction mixture for assaying Gn-T activity contained 14
mM HEPES buﬀer, pH 7.4, an appropriate concentration of UDP-
GlcNAc, 10 mM MnCl2, 0.15% Triton CF-54, 0.75 mM ATP, a suit-
able amount of acceptor substrate, and the puriﬁed enzyme. After
incubation at 37 C for 16 h, the product was analyzed using various
techniques as described below.
A Gn-T assay of human b3Gn-T8 using the oligosaccharides was
performed as follows: 50 lM UDP-GlcNAc (Sigma), 4.5 lM (50
nCi) [14C]UDP-GlcNAc (Amersham Biosciences, Amersham Place,
UK) and 10 lM of acceptor substrate were added to 20 ll of the basic
reaction mixture. The acceptor substrate used in this study, listed in
Table 1, was purchased from Calbiochem (La Jolla, CA), Sigma and
Toronto Research Chemicals Inc. (Ontario, Canada). As summarized
in Table 2, the Gn-T assay for N-glycans was performed using pyr-
idylaminated substrates: 2 lM of pyridylaminated acceptor substrate
(TaKaRa, Japan) and 50 lM UDP-GlcNAc (Sigma) were added to
the basic reaction mixture. The ﬂuorescence intensity of the products
was determined by HPLC on a PALPAK type R column (4.6 · 250
mm; TaKaRa) according to the instruction manual. Parallel reactions
as controls were done in the absence of UDP-GlcNAc to identify the
products.
2.3. N-acetylglucosaminyltransferase assay with glycoproteins
The transfer of GlcNAc by b3Gn-T8 to glycoproteins was per-
formed in 20 ll of a basic reaction mixture, containing 50 lM
UDP-GlcNAc, 4.5 lM (50 nCi) UDP-[14C]GlcNAc, and 40 lg of
a1-acid glycoprotein (Sigma) or ovomucoid (Sigma). After incubation
at 37 C for 16 h, the enzyme reaction was terminated by treatment at
100 C for 3 min, then 2.5 ll of reaction mixture was treated with
H2O or Glycopeptidase F (GPF, TaKaRa, Ohtsu, Japan) under dena-
turing conditions according to the instruction manual, and subjected
to 10% SDS–PAGE. The radioactive intensities of the bands obtained
were measured with a FLA-3000 Imaging Analyzer (Fujiﬁlm, Tokyo,
Japan).
Table 2
Substrate speciﬁcity of recombinant b3Gn-Ts for N-glycans
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cell lines by real-time PCR
For quantiﬁcation of the b3Gn-T8 transcript, we employed the real
time PCR method, as described in detail previously [4]. Total RNA
from various human tissues was purchased from Clontech. Normal
and cancerous tissues of human colon were obtained from 13 colorec-
tal cancer patients as surgically resected specimens at Fussa Hospital
(Tokyo, Japan). The tissues were frozen in liquid nitrogen immediately
after surgical resection and stored in liquid nitrogen until RNA extrac-
tion. Total cellular RNA was isolated from tissues using an RNeasy
Mini kit (Qiagen, Hilden, Germany). Complementary DNAs were syn-
thesized using oligo(dT)12–18 primers and the Superscript First-Strand
Synthesis system (Invitrogen). Standard curves for the endogenous
control, glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
cDNA, were generated by serial dilution of pCR2.1 (Invitrogen)
DNA containing the GAPDH gene. A standard curve for b3Gn-T8
cDNA was generated by serial dilution of pBluescript SKII() DNA
containing the ORF of b3Gn-T8. The primer set and probe for
b3Gn-T8 were as follows: forward primer, 5 0-GCTGTTGGCCGTC-
AAGTCAG-3 0; reverse primer, 5 0-CAGGAAGAGCAGCCGGAT-
3 0; and probe, 5 0-CAGAACGACAGGCCGTGA-3 0. Primers, probe,
and cDNA were added to the TaqMan Universal PCR Master Mix
(Applied Biosystems, Foster City, CA), which contained all reagents
for PCR. The PCR conditions included 1 cycle at 50 C for 2 min, 1cycle at 95 C for 10 min, and 50 cycles at 95 C for 15 s, and 60 C
for 1 min. PCR products were measured continuously with an ABI
PRISM 7700 Sequence Detection System (Applied Biosystems). The
relative amount of the transcript was normalized to the amount of
GAPDH transcript in the same cDNA or the amount of total RNA.
2.5. Construction of vector for expression of b3Gn-T8 in mammalian
cultured cells
The fragment of the ORF encoding b3Gn-T8 was ampliﬁed by PCR
from Colo205 cDNA as a template, and two primers, 5 0-CTCAAGCT-
TATGCGCTGCCCCAAGTGCCTTC-3 0 and 5 0-CTCGAATTC-
CAGCACTGGAGCCTTGGGTCT-3 0. The ampliﬁed fragment
was digested with the restriction endonucleases HindIII and EcoRI,
then inserted into pcDNA3.1(+) (Invitrogen) to construct pcDNA3.1-
b3Gn-T8.
2.6. Cell culture and transfection
The tumor cell lines were cultured in RPMI1640 medium (GIBCO
BRL, Rockville, MD) supplemented with 10% fetal bovine serum.
HCT15 cells, a human colon adenocarcinoma cell line, were transfec-
ted with pcDNA3.1-b3Gn-T8 DNA using Lipofectamin 2000 reagent
(Invitrogen). At 48 h after the transfection, the cells were subjected
to ﬂow cytometric analysis.
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For ﬂow cytometry, the cells were incubated with ﬂuorescein isothi-
ocyanate (FITC)-conjugated Lycopersicon esculentum agglutinin
(LEA; Vector Lab. Inc., CA) and Phaseolus vulgaris-L4 (PHA-L4;
Honen, Japan). After incubation, the cells were subjected to ﬂow cyto-
metric analysis with a FACSCalibur (BD Biosciences, CA).3. Results and discussion
3.1. Determination of nucleotide and amino acid sequence of
b3Gn-T8
We obtained a new sequence for the b3-GT family as de-
scribed under Section 2 and named it b3Gn-T8. An alignment
of the amino acid sequence with that of other b3Gn-Ts using
ClustalW is shown in Fig. 1. The 1194-bp (397 amino acids)
ORF of b3Gn-T8 encoded a typical type II membrane protein,
the same as in other b3Gn-Ts, consisting of an N-terminal
cytoplasmic domain of 4 residues, a transmembane segment
of 19 residues, and a stem region and a putative catalytic do-
main of 374 residues. A comparison of the amino acid se-
quence with that of other b3-glycosyltransferases revealed
that this enzyme lacks the ﬁrst aspartic acid of the DXD motif,
identiﬁed as one of the b3Gn-T motifs and a divalent cation-
binding site by a crystallization study on other glycosyltransfe-
rases [27,28]. Though b3Gn-T8 has an incomplete DXD motif,
a divalent cation, Mn2+, is essential for the enzymatic activity
like for other members of the family (data not shown). Five
cysteine residues were conserved in the seven b3Gn-Ts, which
indicate that some of them are essential for maintenance of the
tertiary structure of b3Gn-Ts. One possible N-glycosylation
site was found in the primary sequence, which was conserved
in all b3Gn-Ts. The b3Gn-T8 gene was found to be localized
to a draft genome sequence (GenBank accession No.
AC011462) which mapped to 19q13.31 on the human chromo-
some, 7A3 on the mouse chromosome, and its ORF is com-
posed of a single exon. As shown in the phylogenetic tree
(Fig. 2), b3Gn-T8 was categorized into a cluster of the
b3Gn-T subfamily. Six members of the b3Gn-T family, includ-
ing b3Gn-T8, formed a cluster which is separated from other
b3-GTs. As mentioned below, we identiﬁed that b3Gn-T8
transfers GlcNAc to Gal residue with a b1–3 linkage as do
the other b3Gn-Ts. The b3Gn-Ts of the cluster catalyze the
synthesis of polylactosamine chains. b3Gn-T5 is positioned
on an outer branch away from the other members. b3Gn-T5
acts on a glycolipid, such as lactosylceramide, resulting in
the synthesis of lactotoriaosylceramide.
3.2. Determination of glycosyltransferase activity and substrate
speciﬁcity of b3Gn-T8
FLAG-tagged recombinant b3Gn-T2, -T7 and -T8 were
puriﬁed from supernatant of 293T cells as described under Sec-
tion 2. The amounts of each enzyme were made equal for
assaying the b3Gn-T activity. Glycosyltransferase activities,
Gal-T, Gn-T and GalNAc-T activities, were screened using
each donor labeled with 14C. No Gal-T or GalNAc-T activity
toward any acceptor substrate was observed (data not shown),
whereas Gn-T activity was exhibited toward Gal b1–4 Glc-
NAc-a-pNp. The optimal pH for the b3Gn-T8 activity was be-
tween 7.0 and 7.5 (data not shown). In general,
glycosyltransferases having a typical DXD(H) motif require
divalent metal ions to exert activity. However, Gn-TV and
IGnT, which have no DXD motif, do not require divalent me-tal ions. b3Gn-T8 has QDD in its amino acid sequence instead
of the DDD motif conserved in the other b3Gn-T members. It
has been reported that the third aspartic acid in the DXD se-
quence in b4Gal-T1 binds to divalent metal ions [28]. b3Gn-T8
showed an absolute requirement for divalent metal ions, such
as Mn2+, and the optimum concentration of Mn2+ was be-
tween 2.5 and 10 mM. We examined the eﬀect of other dicta-
tions, such as Co2+, Cd2+, Zn2+, Ni2+, and Mg2+, and found
that Co2+ slightly aﬀected the enzyme activity to 40% of
the level achieved with Mn2+ at the same concentration. The
other metal ions did not activate the enzyme eﬀectively (data
not shown). Substrate speciﬁcity for mono-, di-saccharide
and core structures of O-glycans is summarized in Table 1.
The activity of b3Gn-T8 toward Galb1–4GlcNAc-a-pNp is
presented as 100%, and all other activities are given as relative
values in Table 1. The activities of b3Gn-T8 toward Galb1–
4GlcNAc-a-pNp and lactoside-a-Bz were almost the same as
those of b3Gn-T7, which is responsible for the synthesis of ker-
atan sulfate [8]. But b3Gn-T8 did not show any activity for
partial structures of keratan sulfates, such as Galb1–4ðSO3
-6ÞGlcNAcb1–3Galb1–4ðSO3 -6ÞGlcNAc ðL2L2Þ; Galb1–4
ðSO3 -6ÞGlcNAcb1–3ðSO3 -6ÞGalb1–4ðSO3 -6ÞGlcNAc ðL2
L4Þ and SO3 -6Galb1–4ðSO3 -6ÞGlcNAcb1–3ðSO3 -6ÞGalb
1–4ðSO3 -6ÞGlcNAc ðL4L4Þ. The oligosaccharide substrates
having the polylactosamine structures, containing repeats of
lactosamine (Galb1–4GlcNAc; LN), were labeled with 2-amin-
obenzamide (2AB) and used as acceptor substrates [1,14]. But
no activity toward any polylactosamine oligosaccharide was
detected in b3Gn-T8 (data not shown).
To determine whether b3Gn-T8 can transfer GlcNAc to gly-
coproteins, a1-acid glycoprotein and ovomucoid, which,
respectively, possess tetraantennary complex type and penta-
antennary complex type N-glycans, were used as acceptor sub-
strates. As shown in Fig. 3, b3Gn-T8 transferred GlcNAc to
these glycoproteins. After digestion of these products with
GPF, radioactive signals disappeared. This result indicated
that N-glycans on these proteins could be acceptor substrates.
No activity was detected for transferrin which has bianntenary
N-glycans (data not shown). So, b3Gn-T8 was speculated to
have enzymatic speciﬁcity for some special structure of N-gly-
cans. Substrate speciﬁcity for N-glycan is summarized in Table
2. The activity of b3Gn-T2 toward tetraantennary N-glycan
without core fucose (Fuca1–6GlcNAc) is presented as 100%
and all other activities are given as relative values. b3Gn-T8
only exhibited activity toward tetraantennary N-glycans, with
or without core fucose. b3Gn-T8 yielded two products from
tetra-antennary N-glycan. One had GlcNAc on a Gal residue
of the b1–2 branch, and the other had GlcNAc on the b1–6
branch. b3Gn-T8 prefers the b1–2 branch to the b1–6 branch
(data not shown). Ujita et al. [29] reported that i-extension en-
zyme (iGnT), which can synthesize polylactosamine chain on
N-glycan, transfers GlcNAc to b1–2 branch more preferen-
tially than b1–6 branch of N-glycan. Though both enzymes,
b3Gn-T8 and iGnT, have a low homology, they show a similar
acceptor speciﬁcity toward tetraantennary N-glycan.3.3. Biosynthesis of polylactosamines in HCT15 cells
To determine the enzymatic activity of b3Gn-T8 in vivo,
HCT15 cells were transfected with pcDNA3.1-b3Gn-T8 or
an empty vector, and examined for changes in the cell surface
expression of carbohydrate chains by ﬂow cytometric analysis
Fig. 1. ClustalW alignment for comparison of b3Gn-T8 with the other six b3Gn-Ts. Introduced gaps are shown with hyphens. The three b3-GT
motifs are boxed. The putative transmembrane domains are underlined. Asterisks indicate the amino acids identical among all proteins. Conserved
amino acids are shown by dots. Triplets of aspartic acid residues, DDD, are exited in the second b3-GT motif. Cysteine residues conserved in the
seven b3Gn-Ts, b3Gn-T2, -T3, -T4, -T5, -T6, -T7, and -T8 are indicated by open arrows. Possible N-glycosylation sites in the b3Gn-T8 sequence are
indicated by bold letters. A possible N-glycosylation site conserved in all proteins is indicated by a closed arrow.
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polylactosamine and b1,6-branched N-glycan, respectively.
As shown in Fig. 4, the transfectants exhibited increased levels
of both LEA and PHA-L4, compared with mock transfectants.This result indicated that b3Gn-T8 is involved in the biosyn-
thesis of polylactosamine chains on the b1,6-branch of N-gly-
can. Considering that b3Gn-T8 only acts on tetraantennary
N-glycans, b3Gn-T8 initiates the elongation of polylactos-
β3Gn-T5
β3Gn-T8
β3Gn-T1/T2
β3Gn-T3
β3Gn-T6
β3Gn-T4
β3Gn-T7
β3GalNAc-T2
β3Gal-T6
β3Gal-T1
β3Gal-T2
β3Gal-T5
β3GalNAc-T1
β3Gal-T4
0.05
Fig. 2. A phylogenetic tree of human b3Gal-Ts, b3GalNAc-Ts and
b3Gn-Ts. A phylogenetic tree of human b3-glycosyltransferases was
constructed by means of the neighbor joining method based on the
amino acid sequences. The branch length indicates the evolutionary
distance between diﬀerent sequences.
Fig. 3. Assay to determine the b3Gn-T8 activity toward a1-acid
glycoprotein and ovomucoid. The reaction mixtures of enzyme and
substrate were not treated () or treated (+) with Glycopeptidase F
(GPF), and then separated by SDS–PAGE. The gels were stained with
CBB (upper panel) or subjected to autoradiography (lower panel).
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Fig. 4. Flow cytometric analysis of HCT15 cells transfected with the
b3Gn-T8 Gene. The expression of lactosamine and b1,6-branching N-
glycans was recognized by LEA and PHA-L4 lectin, respectively.
HCT15/b3Gn-T8 and HCT15/mock stained with and without lectin on
the cell surface were analyzed by ﬂow cytometry. HCT15/b3Gn-T8
cells are stained with lectin (bold line) or without lectin (dotted line) and
HCT15/mock are stained with lectin (thin line) or without lectin
(shaded area), respectively, in each panel.
76 H. Ishida et al. / FEBS Letters 579 (2005) 71–78amine on the b1,2- and/or b1,6-branched structure of N-gly-
can, which is in accord with the structures found in nature.
3.4. Tissue distribution of the b3Gn-T8 transcript
The level of expression of the b3Gn-T8 transcript in various
human tissues was determined by quantitative real-time PCR.
As shown in Fig. 5, this gene was expressed in almost all tissues
except the colon, although the level of expression varied with
the tissue. Tissues expressing high levels of b3Gn-T8 were small
intestine, pancreas, spleen and bone marrow. Those expressing
low levels were fetal brain, cerebellum, heart, liver and testis.
The level in colon was almost undetectable.
The results of the analysis of clinical samples are summa-
rized in Fig. 6. In most cases, the level of b3Gn-T8 transcript
was increased markedly in colon cancer tissues compared to
normal tissue. In addition, most of the cell lines established
from colon cancer showed higher levels of the b3Gn-T8 tran-
script than did the cell lines derived from gastric cancer,
esophageal cancer, hepatocellular carcinoma and pancreas
cancer. Levels of transcript and activity of some glyco-
syltransferases are known to increase in cancerous tissue,
for example, N-acetylglucosaminyltransferase V (GnT-V),
fucosyltransferase IV, and ST3Gal II in colorectal cancer
[30,31]. GnT-V catalyzes b1–6 branching of N-acetylglucos-
amine on N-glycan, and its expression is correlated with
metastasis and poor prognosis in colorectal cancer [30]. The
b1–6 branching structure, the product of GnT-V, is a good
substrate for the attachment of polylactosamine [29]. In a
study on colon carcinoma cell lines, highly metastatic cell
lines were found to synthesize more N-glycans that contain
polylactosamines than poorly metastatic cell lines [32]. The
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lated to form sialyl Lewis X. The expression level of sialyl Le-
wis X is also correlated with tumor recurrence and survival in
colorectal cancer [33].
In this study, we found a novel member of the b3-GT family,
b3Gn-T8, which can extend polylactosamine on N-glycan.
Taking into consideration that the transcripts of b3Gn-T8
are abundant in most colorectal cancer tissue, b3Gn-T8 may
be involved in malignancy, by synthesizing polylactosamine
on b1–6 branched N-glycans, in colon cancer.Acknowledgments: We thank Drs. Hiroko Iwasaki and Nobuo Nak-
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